Senseonics Holdings (SENS) Capital Expenditures Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | 32.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.24% |
| Dec 31, 2025 | -139.39% |
| Sep 30, 2025 | 147.61% |
| Jun 30, 2025 | -92.52% |
| Mar 31, 2025 | 46.87% |
| Dec 31, 2024 | -241.17% |
| Sep 30, 2024 | -109.92% |
| Jun 30, 2024 | 287.33% |
| Mar 31, 2024 | 206.27% |
| Sep 30, 2023 | -8.58% |
| Jun 30, 2023 | 32.41% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 27.28% |
| Sep 30, 2022 | -61.66% |
| Jun 30, 2022 | 32.64% |
| Mar 31, 2022 | -29.56% |
| Dec 31, 2021 | 55.33% |
| Sep 30, 2021 | -61.92% |
| Jun 30, 2021 | -39.55% |
| Mar 31, 2021 | -5.42% |
| Sep 30, 2020 | 16.82% |
| Jun 30, 2020 | -29.40% |
| Mar 31, 2020 | 19.68% |
| Dec 31, 2019 | -230.31% |
| Sep 30, 2019 | 105.50% |
| Jun 30, 2019 | -38.96% |
| Mar 31, 2019 | 119.63% |
| Sep 30, 2018 | 60.34% |
| Jun 30, 2018 | 38.77% |